To evaluate the antidepressant effect of a new treatment principle using low-intensity transcranially applied pulsed electromagnetic fields (T-PEMF) in combination with antidepressants in patients with treatment-resistant depression.
Background/further details
The psychopharmacological treatment (antidepressants, mood stabilizers, antipsychotics, tranquilizers, and hypnotics) was unchanged during the previous four weeks (before treatment) and was maintained on the same dosage throughout the study. In total, 50 patients were included (from June 2006 to February 2009; treatment group n=25, sham exposure group n=25). See here for additional information.
plastic treatment helmet with 7 coils: two in the anterior and posteriortemporal region on both sides, one in the upper parietal region on both sides and one in the center of the lower occipital region
effects on the neurological system: therapy of treatment-resistant depression (clinician-rated and patient-rated scales: Hamilton Depression Rating Scale-17 (HAM-D/17), visual analog scale, melancholia scale and additional other established scales)
Chistyakov AV et al.
(2010):
Safety, tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression
Dell'Osso B et al.
(2009):
Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression
Bermpohl F et al.
(2006):
Effect of low-frequency transcranial magnetic stimulation on an affective go/no-go task in patients with major depression: role of stimulation site and depression severity
Yukimasa T et al.
(2006):
High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors
Rumi DO et al.
(2005):
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study
Shaul U et al.
(2003):
Modulation of frequency and duration of repetitive magnetic stimulation affects catecholamine levels and tyrosine hydroxylase activity in human neuroblastoma cells: implication for the antidepressant effect of rTMS
Janicak PG et al.
(2002):
Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial
Nahas Z et al.
(2001):
Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance
George MS et al.
(2000):
A controlled trial of daily left prefrontal cortex TMS for treating depression
Eschweiler GW et al.
(2000):
Does clinical response to repetitive prefrontal transcranial magnetic stimulation (r TMS) predict response to electroconvulsive therapy (ECT) in cases of major depression?
Klein E et al.
(1999):
Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study
George MS et al.
(1997):
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial
George MS et al.
(1995):
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
